The First Cohort
Medical research, with the receipts
A Gene-Editing Trial Killed a 6-Year-Old. Nature Published the Science and Left Her Out of the Record.
Her parents paid $860,000 to base-edit their daughter's brain. She died of an immune reaction within a week, and the published paper never says so.
The Evolutionary Fix for Drug Resistance Works Best on a Tumor Too Small to Find
City St George's mathematicians say hitting a tumor at its weakest moment can drive it extinct. Their own model shows the window closes as the tumor grows.
More from the newsroom
Orforglipron Reaches Deep Into the Brain's Reward Circuit and Turns the Dopamine Down
Pepsi Paid $1.95 Billion for Poppi, in a Category That Averages as Much Sugar as Fiber
A Chinese Bark Compound Reached the Black-Box Arthritis Drugs' Pathway From Upstream, in Rats
The Sweeteners Sold to Diabetics as the Safe Swap Tracked With Faster Brain Aging
The index
The FDA Revoked Two Petroleum Dyes That Industry Abandoned Before Most Americans Were Born
The Fruit Juice Sold to Parents as the Healthy Choice Tracks With Higher Blood Pressure 25 Years Later
The AHA Says Coffee Is Safe to Five Cups a Day. The Energy Shot's Problem Isn't the Caffeine.
In the Lab, Coffee Flipped an Anti-Aging Switch. The Caffeine Barely Did.
The GLP-1s That Barely Move the Scale Don't Cause Hair Loss, and That's the Clue Everyone Missed
A Gut Microbe Was Feeding Ammonia to Sick Livers. A Michigan Peptide Cut Off the Supply in Monkeys.
Anti-Tau Alzheimer's Drugs Keep Hitting Their Target and Missing the Disease
A Petri Dish of Angry Immune Cells, a Little Ultrasound, and a Very Big Headline